| ABCA7 | ATP-binding cassette sub-family A member 7 |
| AD | Alzheimer’s disease |
| ADCOMS | Alzheimer’s Disease Composite Score |
| ADAS-Cog14 | Alzheimer’s Disease Assessment Scale–Cognitive subscale (14 items) |
| ADCS-ADL-MCI | Alzheimer’s Disease Cooperative Study–Activities of Daily Living for mild cognitive impairment |
| Aβ | amyloid-beta |
| APOE | apolipoprotein E |
| APP | amyloid precursor protein |
| ARIAs | amyloid-related imaging abnormalities |
| ARIA-E | ARIA with edema/effusion |
| ARIA-H | ARIA with cerebral microhemorrhages/siderosis |
| BBB | blood–brain barrier |
| CAA | cerebral amyloid angiopathy |
| CDR-SB | Clinical Dementia Rating–Sum of Boxes |
| CSF | cerebrospinal fluid |
| FDA | Food and Drug Administration |
| GFAP | glial fibrillary acidic protein |
| iADRS | Integrated Alzheimer’s Disease Rating Scale |
| MMSE | mini-mental state examination |
| MRI | magnetic resonance imaging |
| NFT | neurofibrillary tangle |
| NIA-AA ATN framework | National Institute on Aging–Alzheimer’s Association amyloid/tau/neurodegeneration framework |
| PET | positron emission tomography |
| p-Tau | phosphorylated tau |
| PSEN1 | presenilin 1 |
| PSEN2 | presenilin 2 |
| SORL1 | sortilin-related receptor |
| Tau | microtubule-associated protein tau |
| TREM2 | triggering receptor expressed on myeloid cells 2 |